Dr. Sanjay Gupta: Blockbuster weight loss drugs are revealing what we still don’t understand about obesity
Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...
Skye Bioscience Surpasses 50% Patient Enrollment in Phase 2 Obesity Study of Differentiated CB1 Inhibitor
This clinical trial is a randomized, double-blind study designed to enroll 120 patients across four treatment groups. The primary endpoint will evaluate the difference in weight loss of nimacimab ...